(Q73840618)
Statements
Optimized basal-bolus therapy using a fixed mixture of 75% lispro and 25% NPL insulin in type 1 diabetes patients: no favorable effects on glycemic control, physiological responses to hypoglycemia, well-being, or treatment satisfaction (English)
M M Janssen
F J Snoek
N Masurel
R P Hoogma
W L Devillé